207 related articles for article (PubMed ID: 34235860)
1. HIV-1 proviral landscape characterization varies by pipeline analysis.
Ferreira FA; He Q; Banning S; Roberts-Sano O; Wilkins O; Kuritzkes DR; Tsibris A
J Int AIDS Soc; 2021 Jul; 24(7):e25725. PubMed ID: 34235860
[TBL] [Abstract][Full Text] [Related]
2. Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life.
Katusiime MG; Halvas EK; Wright I; Joseph K; Bale MJ; Kirby-McCullough B; Engelbrecht S; Shao W; Hu WS; Cotton MF; Mellors JW; Kearney MF; van Zyl GU
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776265
[TBL] [Abstract][Full Text] [Related]
3. Sequence Evaluation and Comparative Analysis of Novel Assays for Intact Proviral HIV-1 DNA.
Gaebler C; Falcinelli SD; Stoffel E; Read J; Murtagh R; Oliveira TY; Ramos V; Lorenzi JCC; Kirchherr J; James KS; Allard B; Baker C; Kuruc JD; Caskey M; Archin NM; Siliciano RF; Margolis DM; Nussenzweig MC
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361426
[TBL] [Abstract][Full Text] [Related]
4. Deep Sequencing Analysis of Individual HIV-1 Proviruses Reveals Frequent Asymmetric Long Terminal Repeats.
Joseph KW; Halvas EK; Brandt LD; Patro SC; Rausch JW; Chopra A; Mallal S; Kearney MF; Coffin JM; Mellors JW
J Virol; 2022 Jul; 96(13):e0012222. PubMed ID: 35674431
[TBL] [Abstract][Full Text] [Related]
5. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time.
Shahid A; MacLennan S; Jones BR; Sudderuddin H; Dang Z; Cobarrubias K; Duncan MC; Kinloch NN; Dapp MJ; Archin NM; Fischl MA; Ofotokun I; Adimora A; Gange S; Aouizerat B; Kuniholm MH; Kassaye S; Mullins JI; Goldstein H; Joy JB; Anastos K; Brumme ZL;
J Virol; 2024 Feb; 98(2):e0165523. PubMed ID: 38214547
[TBL] [Abstract][Full Text] [Related]
6. In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control.
Trémeaux P; Lemoine F; Mélard A; Gousset M; Boufassa F; Orr S; Monceaux V; Gascuel O; Lambotte O; Hocqueloux L; Saez-Cirion A; Rouzioux C; Avettand-Fenoel V
Microbiol Spectr; 2023 Feb; 11(1):e0326722. PubMed ID: 36692300
[TBL] [Abstract][Full Text] [Related]
7. New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir.
Patro SC; Niyongabo A; Maldarelli F; Kearney MF
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960744
[TBL] [Abstract][Full Text] [Related]
8. Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4
Jones BR; Miller RL; Kinloch NN; Tsai O; Rigsby H; Sudderuddin H; Shahid A; Ganase B; Brumme CJ; Harris M; Poon AFY; Brockman MA; Fromentin R; Chomont N; Joy JB; Brumme ZL
J Virol; 2020 Feb; 94(5):. PubMed ID: 31776273
[TBL] [Abstract][Full Text] [Related]
9. NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology.
Wright IA; Delaney KE; Katusiime MGK; Botha JC; Engelbrecht S; Kearney MF; van Zyl GU
Cells; 2021 Sep; 10(10):. PubMed ID: 34685559
[TBL] [Abstract][Full Text] [Related]
10. Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors.
Patro SC; Brandt LD; Bale MJ; Halvas EK; Joseph KW; Shao W; Wu X; Guo S; Murrell B; Wiegand A; Spindler J; Raley C; Hautman C; Sobolewski M; Fennessey CM; Hu WS; Luke B; Hasson JM; Niyongabo A; Capoferri AA; Keele BF; Milush J; Hoh R; Deeks SG; Maldarelli F; Hughes SH; Coffin JM; Rausch JW; Mellors JW; Kearney MF
Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25891-25899. PubMed ID: 31776247
[TBL] [Abstract][Full Text] [Related]
11. The HIV-2 proviral landscape is dominated by defective proviruses.
Koofhethile CK; Gao C; Chang C; Lian X; Shapiro R; Yu XG; Lichterfeld M; Kanki PJ
AIDS; 2024 Mar; 38(3):309-316. PubMed ID: 37916471
[TBL] [Abstract][Full Text] [Related]
12. Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing.
Hiener B; Eden JS; Horsburgh BA; Palmer S
J Vis Exp; 2018 Oct; (140):. PubMed ID: 30394382
[TBL] [Abstract][Full Text] [Related]
13. Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy.
Sun W; Rassadkina Y; Gao C; Collens SI; Lian X; Solomon IH; Mukerji SS; Yu XG; Lichterfeld M
Elife; 2023 Nov; 12():. PubMed ID: 37938115
[TBL] [Abstract][Full Text] [Related]
14. Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy.
Gabuzda D; Yin J; Misra V; Chettimada S; Gelman BB
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112989
[TBL] [Abstract][Full Text] [Related]
15. Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections.
Anderson EM; Simonetti FR; Gorelick RJ; Hill S; Gouzoulis MA; Bell J; Rehm C; Pérez L; Boritz E; Wu X; Wells D; Hughes SH; Rao V; Coffin JM; Kearney MF; Maldarelli F
Viruses; 2020 Jan; 12(2):. PubMed ID: 31991737
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing.
Cho A; Gaebler C; Olveira T; Ramos V; Saad M; Lorenzi JCC; Gazumyan A; Moir S; Caskey M; Chun TW; Nussenzweig MC
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35042816
[TBL] [Abstract][Full Text] [Related]
17. The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers.
Gasca-Capote C; Lian X; Gao C; Roseto IC; Jiménez-León MR; Gladkov G; Camacho-Sojo MI; Pérez-Gómez A; Gallego I; Lopez-Cortes LE; Bachiller S; Vitalle J; Rafii-El-Idrissi Benhnia M; Ostos FJ; Collado-Romacho AR; Santos J; Palacios R; Gomez-Ayerbe C; Muñoz-Medina L; Ruiz-Sancho A; Frias M; Rivero-Juarez A; Roca-Oporto C; Hidalgo-Tenorio C; Rull A; Olalla J; Lopez-Ruz MA; Vidal F; Viladés C; Mastrangelo A; Cavassini M; Espinosa N; Perreau M; Peraire J; Rivero A; López-Cortes LF; Lichterfeld M; Yu XG; Ruiz-Mateos E
J Clin Invest; 2024 Feb; 134(8):. PubMed ID: 38376918
[TBL] [Abstract][Full Text] [Related]
18. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy.
Gandhi RT; Cyktor JC; Bosch RJ; Mar H; Laird GM; Martin A; Collier AC; Riddler SA; Macatangay BJ; Rinaldo CR; Eron JJ; Siliciano JD; McMahon DK; Mellors JW;
J Infect Dis; 2021 Feb; 223(2):225-233. PubMed ID: 32823274
[TBL] [Abstract][Full Text] [Related]
19. Near-Full-Length Single-Genome HIV-1 DNA Sequencing.
Lee GQ; Lichterfeld M
Methods Mol Biol; 2022; 2407():357-364. PubMed ID: 34985675
[TBL] [Abstract][Full Text] [Related]
20. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.
Omondi FH; Sudderuddin H; Shahid A; Kinloch NN; Jones BR; Miller RL; Tsai O; MacMillan D; Trocha A; Brockman MA; Brumme CJ; Joy JB; Liang R; Walker BD; Brumme ZL
mBio; 2021 Dec; 12(6):e0249021. PubMed ID: 34781741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
